ImmuCell Corp (ICCC)
5.05
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
5.06
+0.01
(+0.20%)
After-Hours: 20:00
ImmuCell Cash from Investing (TTM): -1.89M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.89M |
September 30, 2023 | -3.414M |
June 30, 2023 | -3.615M |
March 31, 2023 | -3.850M |
December 31, 2022 | -3.964M |
September 30, 2022 | -3.177M |
June 30, 2022 | -3.114M |
March 31, 2022 | -3.050M |
December 31, 2021 | -1.597M |
September 30, 2021 | -0.1378M |
June 30, 2021 | -0.9395M |
March 31, 2021 | -2.627M |
December 31, 2020 | -2.570M |
September 30, 2020 | 0.8763M |
June 30, 2020 | 3.690M |
March 31, 2020 | -2.487M |
December 31, 2019 | -3.403M |
September 30, 2019 | -7.705M |
June 30, 2019 | -9.019M |
March 31, 2019 | -0.7783M |
December 31, 2018 | -1.794M |
September 30, 2018 | -6.376M |
June 30, 2018 | -10.38M |
March 31, 2018 | -11.08M |
December 31, 2017 | -12.27M |
Date | Value |
---|---|
September 30, 2017 | -9.605M |
June 30, 2017 | -4.845M |
March 31, 2017 | -4.766M |
December 31, 2016 | -4.524M |
September 30, 2016 | -4.204M |
June 30, 2016 | -7.506M |
March 31, 2016 | -7.049M |
December 31, 2015 | -4.619M |
September 30, 2015 | -3.447M |
June 30, 2015 | -1.131M |
March 31, 2015 | -0.9816M |
December 31, 2014 | -1.536M |
September 30, 2014 | -1.741M |
June 30, 2014 | -1.072M |
March 31, 2014 | -0.8806M |
December 31, 2013 | -1.343M |
September 30, 2013 | 0.351M |
June 30, 2013 | 0.6221M |
March 31, 2013 | 0.3261M |
December 31, 2012 | 1.663M |
September 30, 2012 | 0.6406M |
June 30, 2012 | -0.1241M |
March 31, 2012 | 0.7132M |
December 31, 2011 | -1.195M |
September 30, 2011 | -2.146M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-9.019M
Minimum
Jun 2019
3.690M
Maximum
Jun 2020
-2.737M
Average
-3.050M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Ampio Pharmaceuticals Inc | -- |